Virtu KCG Holdings’s Repros Therapeutics Inc. RPRX Stock Holding History

Virtu KCG Holdings’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-45,144	Closed	-$60K	–	4258
2016 Q4	$60K	Buy	45,144 +19,169	+74%	+$33.3K	﹤0.01%	3052
2016 Q3	$54K	Buy	+25,975	New	+$51.4K	﹤0.01%	2771
2016 Q2	–	Sell	-28,386	Closed	-$28K	–	3735
2016 Q1	$28K	Sell	28,386 -52,730	-65%	-$51.4K	﹤0.01%	2558
2015 Q4	$98K	Buy	+81,116	New	+$260K	﹤0.01%	3001
2015 Q3	–	Sell	-13,518	Closed	-$97K	–	4370
2015 Q2	$97K	Buy	+13,518	New	+$105K	﹤0.01%	2922
2013 Q4	–	Sell	-14,472	Closed	-$388K	–	4740
2013 Q3	$388K	Buy	+14,472	New	+$310K	﹤0.01%	2313

Other funds holding RPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

AIA

Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Virtu KCG Holdings's RPRX Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Repros Therapeutics Inc. (RPRX) in Q1 2017, closing a stake of 45,144 shares — an estimated $60K sold.

Virtu KCG Holdings first reported a position in RPRX in Q3 2013 and held it in 6 quarters. The position peaked at $388K in Q3 2013. 33 funds tracked by Wall St. Rank hold RPRX as of Q1 2017.

Virtu KCG Holdings reported no remaining Repros Therapeutics Inc. position as of Q1 2017 after selling out during the quarter.
Virtu KCG Holdings sold 45,144 Repros Therapeutics Inc. shares in Q1 2017, an estimated $60K.
Virtu KCG Holdings first reported a position in Repros Therapeutics Inc. in Q3 2013 and held it in 6 quarters.
Virtu KCG Holdings's Repros Therapeutics Inc. position peaked at $388K in Q3 2013.
33 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.